
Joseph J. Kukella
Examiner (ID: 18482, Phone: (571)272-4679 , Office: P/2913 )
| Most Active Art Unit | 2913 |
| Art Unit(s) | 2961, 2913 |
| Total Applications | 1553 |
| Issued Applications | 1431 |
| Pending Applications | 3 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20459335
[patent_doc_number] => 20260008758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/323862
[patent_app_country] => US
[patent_app_date] => 2025-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19323862
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/323862 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | Sep 8, 2025 | Pending |
Array
(
[id] => 20426502
[patent_doc_number] => 20250388589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-25
[patent_title] => TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/308305
[patent_app_country] => US
[patent_app_date] => 2025-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19308305
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/308305 | TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF | Aug 23, 2025 | Pending |
Array
(
[id] => 20364012
[patent_doc_number] => 20250353824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-20
[patent_title] => 3-PHENYLPROPYLAMINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 19/177410
[patent_app_country] => US
[patent_app_date] => 2025-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19177410
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/177410 | 3-PHENYLPROPYLAMINE DERIVATIVE | Apr 10, 2025 | Pending |
Array
(
[id] => 19497622
[patent_doc_number] => 20240336640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/744642
[patent_app_country] => US
[patent_app_date] => 2024-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18744642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/744642 | CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS | Jun 15, 2024 | Pending |
Array
(
[id] => 20535698
[patent_doc_number] => 12552762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Fluorolactone and method for producing same
[patent_app_type] => utility
[patent_app_number] => 18/741170
[patent_app_country] => US
[patent_app_date] => 2024-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8898
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18741170
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/741170 | Fluorolactone and method for producing same | Jun 11, 2024 | Issued |
Array
(
[id] => 19479367
[patent_doc_number] => 20240327409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/741740
[patent_app_country] => US
[patent_app_date] => 2024-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18741740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/741740 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | Jun 11, 2024 | Pending |
Array
(
[id] => 19709213
[patent_doc_number] => 20250019355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => Compounds
[patent_app_type] => utility
[patent_app_number] => 18/631725
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631725 | Compounds | Apr 9, 2024 | Pending |
Array
(
[id] => 19332492
[patent_doc_number] => 20240246922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/608369
[patent_app_country] => US
[patent_app_date] => 2024-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608369
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/608369 | ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY | Mar 17, 2024 | Pending |
Array
(
[id] => 20158181
[patent_doc_number] => 12384792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 18/583627
[patent_app_country] => US
[patent_app_date] => 2024-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 37
[patent_no_of_words] => 112574
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18583627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/583627 | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same | Feb 20, 2024 | Issued |
Array
(
[id] => 19217792
[patent_doc_number] => 20240182496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => NOVEL PROCESS FOR THE PREPARATION TAVABOROLE AND ITS INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 18/442417
[patent_app_country] => US
[patent_app_date] => 2024-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18442417
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/442417 | NOVEL PROCESS FOR THE PREPARATION TAVABOROLE AND ITS INTERMEDIATES | Feb 14, 2024 | Abandoned |
Array
(
[id] => 19403581
[patent_doc_number] => 20240287092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 18/437702
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/437702 | 4-phenylpiperidines, their preparation and use | Feb 8, 2024 | Issued |
Array
(
[id] => 19683980
[patent_doc_number] => 20250002525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => Aminosteroids for the Treatment of a PTP1B Associated Disease
[patent_app_type] => utility
[patent_app_number] => 18/425572
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425572
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425572 | Aminosteroids for the Treatment of a PTP1B Associated Disease | Jan 28, 2024 | Pending |
Array
(
[id] => 19332479
[patent_doc_number] => 20240246909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => EBNA1 Inhibitors and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 18/408389
[patent_app_country] => US
[patent_app_date] => 2024-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 424
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18408389
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/408389 | EBNA1 Inhibitors and Methods Using Same | Jan 8, 2024 | Pending |
Array
(
[id] => 19418371
[patent_doc_number] => 20240294494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/407053
[patent_app_country] => US
[patent_app_date] => 2024-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 289917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18407053
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/407053 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | Jan 7, 2024 | Pending |
Array
(
[id] => 19512044
[patent_doc_number] => 20240343730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => 2-PHENYL-3,4-DIHYDROPYRROLO[2,1 -F] [1,2,4]TRIAZINONE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/399861
[patent_app_country] => US
[patent_app_date] => 2023-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18399861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/399861 | 2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Dec 28, 2023 | Issued |
Array
(
[id] => 19112652
[patent_doc_number] => 20240124402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN
[patent_app_type] => utility
[patent_app_number] => 18/395979
[patent_app_country] => US
[patent_app_date] => 2023-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18395979
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/395979 | METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN | Dec 25, 2023 | Pending |
Array
(
[id] => 19233634
[patent_doc_number] => 20240190826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics
[patent_app_type] => utility
[patent_app_number] => 18/536755
[patent_app_country] => US
[patent_app_date] => 2023-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18536755
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/536755 | Host-targeted pan-respiratory antiviral small molecule therapeutics | Dec 11, 2023 | Issued |
Array
(
[id] => 19233677
[patent_doc_number] => 20240190869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/532547
[patent_app_country] => US
[patent_app_date] => 2023-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18532547
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/532547 | 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES | Dec 6, 2023 | Pending |
Array
(
[id] => 20158196
[patent_doc_number] => 12384808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Modulators of TNF-a activity
[patent_app_type] => utility
[patent_app_number] => 18/516560
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67665
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18516560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/516560 | Modulators of TNF-a activity | Nov 20, 2023 | Issued |
Array
(
[id] => 19172390
[patent_doc_number] => 20240158364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/511612
[patent_app_country] => US
[patent_app_date] => 2023-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18511612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/511612 | Urolithin derivatives and methods of use thereof | Nov 15, 2023 | Issued |